drugset / Trial / NCT00983151
Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation
RandomizedParallel-groupDouble-blind
Summary
The purpose of this clinical trial is to test an experimental drug therapy called Tramadol Hydrochloride (HCl) Orally Disintegrating Tablets (ODT) ("Tramadol HCl ODT" or the "study drug"). The subject and his partner are being asked to be in this clinical trial because they have a condition called premature ejaculation.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tramadol | Other / unclassified | 62 mg | Oral |
| Subject | Tramadol | Other / unclassified | 89 mg | Oral |